Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8+ T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8+ T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-25
DOI
10.3389/fonc.2020.582863
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of CXCR4 and CXCL10 as Potential Predictive Biomarkers in Triple Negative Breast Cancer (TNBC)
- (2020) Tian Chuan et al. MEDICAL SCIENCE MONITOR
- Two-Faced Roles of Tumor-Associated Neutrophils in Cancer Development and Progression
- (2020) Naofumi Mukaida et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Visualizing and interpreting cancer genomics data via the Xena platform
- (2020) Mary J. Goldman et al. NATURE BIOTECHNOLOGY
- Interleukin‐17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma
- (2019) Aeri Aotsuka et al. CANCER SCIENCE
- High A20 expression negatively impacts survival in patients with breast cancer
- (2019) Chang Ik Yoon et al. PLoS One
- Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells
- (2017) Xun Wang et al. IMMUNOLOGY LETTERS
- Impact of intra-tumoral IL17A and IL32 gene expression on T-cell responses and lymph node status in breast cancer patients
- (2017) Shreyas Bhat et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer
- (2016) Yun-Feng Ma et al. Oncotarget
- Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
- (2016) H. Raza Ali et al. PLOS MEDICINE
- PD-L1 expression and CD274 gene alteration in triple-negative breast cancer: implication for prognostic biomarker
- (2016) Lei Guo et al. SpringerPlus
- IL-17-producing γδT cells are regulated by estrogen during development of experimental arthritis
- (2015) Annica Andersson et al. CLINICAL IMMUNOLOGY
- Inflammatory breast cancer: An overview
- (2015) D.J.P. van Uden et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
- (2015) Itay Raphael et al. CYTOKINE
- Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer
- (2015) F Amicarella et al. GUT
- IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
- (2015) Seth B. Coffelt et al. NATURE
- Basic biology and role of interleukin-17 in immunity and inflammation
- (2015) Camille Zenobia et al. PERIODONTOLOGY 2000
- Prognostic and predictive value of PDL1 expression in breast cancer
- (2015) Renaud Sabatier et al. Oncotarget
- Th17 Cell Plasticity and Functions in Cancer Immunity
- (2015) Leslie Guéry et al. Biomed Research International
- The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancers
- (2015) François Bertucci et al. OncoImmunology
- Intratumoral CD8+ Cytotoxic Lymphocyte Is a Favorable Prognostic Marker in Node-Negative Breast Cancer
- (2014) Zonglin Chen et al. PLoS One
- IL-17 family: Cytokines, receptors and signaling
- (2013) Chunfang Gu et al. CYTOKINE
- Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor
- (2013) Wen-Chung Chen et al. HISTOPATHOLOGY
- The Deubiquitinase A20 Mediates Feedback Inhibition of Interleukin-17 Receptor Signaling
- (2013) A. V. Garg et al. Science Signaling
- IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2
- (2013) Stéphanie Cochaud et al. Scientific Reports
- IL-17 mediates estrogen-deficient osteoporosis in an Act1-dependent manner
- (2012) Carl J. DeSelm et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Interleukin-17, produced by lymphocytes, promotes tumor growth and angiogenesis in a mouse model of breast cancer
- (2012) JIU-WEI DU et al. Molecular Medicine Reports
- Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25
- (2012) Bo Zhong et al. NATURE IMMUNOLOGY
- Estrogen Deficiency Induces the Differentiation of IL-17 Secreting Th17 Cells: A New Candidate in the Pathogenesis of Osteoporosis
- (2012) Abdul M. Tyagi et al. PLoS One
- Expression of Th17 Cells in Breast Cancer Tissue and Its Association with Clinical Parameters
- (2011) LiJuan Yang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- IL-17F: Regulation, signaling and function in inflammation
- (2009) Seon Hee Chang et al. CYTOKINE
- The inflammatory chemokines CCL2 and CCL5 in breast cancer
- (2008) Gali Soria et al. CANCER LETTERS
- Transforming Growth Factor Subverts the Immune System into Directly Promoting Tumor Growth through Interleukin-17
- (2008) J.-S. Nam et al. CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started